Wishbone Medical Appoints Jeff George to Board of Directors
August 12 2020 - 8:01AM
WishBone Medical, Inc., a leader in pediatric orthopedic medical
devices, is pleased to announce the appointment of Jeff George,
global healthcare executive and investor, to the company’s board of
directors, effective August 12, 2020.
“As WishBone takes on more opportunities and acquisitions, it is
important to add expertise and capital, of which Jeff George
provides both,” said Nick Deeter, founder, Chairman, and CEO of
WishBone Medical. “Emerging growth companies like ours go through
numerous phases in their development. Jeff is an extremely
important addition to the Board – he will help WishBone to
implement the plan and become the undisputed leader in pediatric
orthopedics. WishBone has moved at light speed to raise standards
for the 95%* of children who still receive adult implants that are
not FDA-cleared for pediatric use. As the first and only pediatric
orthopedic company operating with a 'single-use' business model,
we’re on track to fully mitigate this issue once and for all.”
Jeff is currently Managing Partner of Maytal Capital, a
healthcare-focused private equity and venture capital investment
and advisory firm he founded in 2017, and an Operating Partner at
Revival Healthcare Capital, a medical device-focused private equity
firm based in Texas. He serves on the Board of Directors at
Amneal Pharmaeuticals (NYSE: AMRX), a leading specialty and generic
pharmaceuticals company, and at Roam Analytics, a Silicon
Valley-based artificial intelligence healthcare software firm. From
2008 to 2016, Jeff served on the Executive Committee of
Switzerland-based Novartis Group AG, one of the world's largest
pharmaceutical companies, where he served as Division Head &
CEO of Sandoz, Novartis’s $10 billion generic pharmaceuticals and
biosimilars subsidiary headquartered in Munich, Germany and then as
Division Head & CEO of Texas-based Alcon, Novartis’s then $10
billion eyecare subsidiary.
“WishBone is an exciting, mission-driven, and rapidly-growing
leader in pediatric orthopedics, and I am honored to join the
Board,” said Jeff George. “Spending time with Nick and his
leadership team the past year has given me strong conviction that
WishBone is poised for continued break-out growth as we work to
meet the significant unmet need for kids in this important field. I
look forward to partnering with Nick and the Board to support
WishBone as it scales in the US and globally.”
Jeff holds an MBA from Harvard Business School and a master’s
degree from Johns Hopkins University’s School of Advanced
International Studies (SAIS), where he studied international
economics and emerging markets political economy. He received
his B.A. in international relations, magna cum laude and Phi Beta
Kappa, from Carleton College. An active volunteer, Jeff also
serves on the board of directors for several non-profit
organizations, including Education Opens Doors (where he is
Chairman), the North Texas Food Bank, and the Young Presidents’
Organization (YPO) of Dallas. He previously served on the
Board of Directors for AdvaMed, the medical device industry
association. Both he and Maytal Capital are based in Dallas,
Texas.
*Data on file.
About WishBone MedicalWishBone
Medical is a global pediatric orthopedic company, committed to
providing anatomically appropriate innovative implants, instruments
and biologics in single-use, sterile packed procedure kits,
designed to prevent infection, reduce overall costs for customers
and achieve the best outcomes for children around the world who are
still growing. The WishBone Medical Family of Companies offers 42
product systems with operations in Warsaw, IN, Istanbul, and
Singapore.
For further information, visit WishBoneMedical.com or
contact Kaitlyn Hughes, Director of Marketing & Communications,
at +1-574-306-4006.
Contact:Kaitlyn
Hughes+1-574-306-4006KHughes@WishBoneMedical.comWishBoneMedical.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024